Form PRER14A Cerevel Therapeutics

Related Keywords

Massachusetts ,United States ,Japan ,Delaware ,North Chicago ,Illinois ,Russia ,Boston ,Ukraine ,State Of Delaware ,Iran ,Crimea ,Villa Clara ,Cuba ,New York ,Syria ,District Of Columbia ,Canada ,Venezuela ,North Korea ,New Hampshire ,Washington ,Cambridge ,Cambridgeshire ,United Kingdom ,Lebanon ,Luhansk ,Luhans Ka Oblast ,Israel ,Japanese ,America ,American ,Russian Federation ,Daniele Rees ,Raymond Sanchez ,Deborah Baron ,Gabrielle Sulzberger ,Abraham Ceesay ,N Anthony Coles ,Kathleen Tregoning ,Mark Bodenrader ,Kenneth Dipietro ,Scott Akamine ,Ericl Schiele ,Norbert Riedel ,Doug Giordano ,Ron Renaud ,Carlo Zenkner ,Scottt Reents ,Scott Reents ,Ronald Renaud ,Paul Burgess ,Dsusan Altschuller ,Tony Coles ,John Mei ,Richard Gonzalez ,John Renger ,Suneet Varma ,Christopher Gordon ,Joseph Edelman ,Novalis Lifesciences ,Adam Koppel ,Nicholas Donoghoe ,Deval Patrick ,Ruth Mckernan ,Charlesk Ruck ,Company Shares On Nasdaq ,Dear Stockholders Of Cerevel Therapeutics Holdings Inc ,Person Of The Company ,Trust Company ,Parent Related Party ,Latham Watkins ,Centers For Disease ,Mackenzie Partners Inc ,Company Or Merger Sub ,Business Development ,No Presumption Against Drafting Party ,United States Federal Trade Commission ,Business Of The Company ,Research Programs ,Company Related ,Reuters ,Centerview Partners ,Company Board ,Company Of The Termination Fee ,Company Shares Under Section ,Company Product Or Intellectual Property Rights ,Federal Reserve ,Company Share On Nasdaq ,Securities Exchange ,Bc Perception Holdings ,Company Products ,Certificate Of Incorporation The Surviving Corporation ,Stockholder Of The Company ,United States Public Health Service ,Immunogen Inc ,Company Disclosure Letter ,Liabilities Of The Surviving Corporation ,Common Stock Of The Company ,Nasdaq ,Company Securities Or Subsidiary ,Third Party Beneficiaries ,Company Securities ,European Medicines Agency ,Company Psus ,Partners Of Bain Capital Investors ,Company Registered Intellectual Property Right ,Company Related Party ,Uop Inc ,Ronaldc Renaud Jr ,Product Development ,Company Or Parent ,None Of The Company ,American Institute Of Certified Public Accountants ,Company Preferred Stock ,Treatment Of Equity Awardsand The Company ,Company Share ,Party Transactions ,No Further Ownership Rights In Company ,Cerevel To Party ,Company Board Approval ,Bloomberg ,Partner Of Bain Capital Life Sciences Investors ,Company Common Stock ,Investors Service Inc ,Company Registered Intellectual Property Rights ,Subsidiary Of The Company ,Company Material Adverse Effect ,Symphony Harlan Merger Sub Inc ,Distribution Of Exchange Fund To Parent ,Company Intellectual Property Right ,Moody ,Company Licensor ,Company Subsidiary Securities ,Opinion Of Financial Advisor The Company ,Affiliate Of The Company ,Company Stockholders ,National Association ,Master Fund ,Partner Of Bain Capital Investors ,Third Party Consent Payments ,York Stock Exchange ,Perceptive Advisors ,Exchange Fund ,Symphony Harlan ,Research Collaboration ,Health Care Law ,United States Internal Revenue Service ,United States Department Of Justice ,Fairness Opinion Committee ,Subsidiaries Of The Company ,Company Stockholder Meeting ,Delaware Supreme Court ,Cerevel Therapeutics ,Company Budget ,Pfizer Inc ,Company Intellectual Property Rights To Product ,Revenue Service ,Company Stock ,Arena Pharmaceuticals Inc ,Counsel To Party ,Company Shares ,Payment For Company ,Effect Of The Merger On Company ,Tax Of The Company ,European Union ,Knowledge Of The Company ,No Third Party Beneficiaries ,Partyb Party ,Us Department Of Justice ,Company Rsus ,Corporation Law Of The State Delaware ,Payment For Company Securities ,Health Care Laws ,Board Of Directors The Company ,Bain Capital Life Sciences Fund ,Us Bank Trust Company ,Dissenting Company Share ,European Commission ,Governmental Authority ,Partyc Representatives Of Centerview ,Neither The Company ,Third Party Consent Payment ,Company Stockholder ,Exchange Act ,Abbvie Inc ,Opinion Of Centerview Partners ,Liability For The Company ,Company Share On ,Pfizer ,Company Product ,Bylaws Of The Surviving Corporation ,Opinion Of Centerviewpartners ,Bain Capital Life Sciences ,Company Stock Plan ,Company To Parent ,Company Shares Held ,Subsidiary Of The Surviving Corporation ,Company Shares Or Book ,Company Options ,Company Stock Award ,Company Impairment Effect ,Cerevel Therapeutics Holdings Inc ,Research Program ,Performance Of Obligations The Company ,Bain Capital Investors ,Delaware Court ,World Health Organization ,Perceptive Life Sciences Master Fund Ltd ,Capital Investors ,Pfizer Research Collaboration Agreement ,Kirkland Ellis ,Solenis International ,Exchange Act Of The Subject ,Exchange Of Certificates ,Company Board Recommendation ,Drug Administration ,Nasdaq Stock Market ,Company Stockholder Approval ,Deregistration Of Company ,No Governmental Authority ,Your Company ,Technicolor Inc ,Exchange Commission ,Equity Award Exchange Ratio ,Diversey Holdings Ltd ,Merger Sub Or Parent Related Party ,Dissenting Company ,New York Stock Exchange ,Company Intellectual Property Rights ,Company Termination Fee ,Statement Pursuant ,Commission Only ,Filing Proxy Statement ,Filing Fee ,Exchange Act Rules ,Preliminary Proxy Statement ,Cerevel Therapeutics Holdings ,Special Meeting ,Merger Agreement ,Intermediate Holdco ,Merger Sub ,Merger Proposal ,Record Date ,Merger Compensation Proposal ,Adjournment Proposal ,Kenzie Partners ,Legal Officer ,Corporate Secretary ,Therapeutics Holdings ,Symphony Harlan Merger Sub ,Nasdaq Capital Market ,Securities Exchange Act ,Merger Consideration ,Effective Time ,General Corporation Law ,Merger Compensation ,Support Agreement ,Subject Shares ,Acquisition Proposal ,Acquisition Transaction ,Cerevel Stockholder Approval ,Continental Stock Transfer ,Chief Executive Officer ,Chief Legal Officer ,Chief Financial Officer ,Depository Trust Company ,Scott Rodino Antitrust Improvements Act ,Cerevel Termination Fee ,Termination Fee ,Certain Expenses ,Executive Officers ,Mackenzie Partners ,Current Report ,Where You Can Find More Information ,Income Tax Consequences ,Company Option ,Existing Company ,New Company ,Incentive Plan ,Equity Incentive Plan ,Equity Awards ,Stock Purchase ,Restated Employee Stock Purchase Plan ,Final Offering Period ,Appraisal Rights ,Waukegan Road ,Shares Entitled ,Dissenting Company Shares ,Excluded Shares ,Closing Date ,Merger Is Not Consummated ,Entry Shares ,Canceled Company Shares ,Equity Award Exchange ,Equity Awardsand ,United States Internal Revenue Code ,Cerevel Acquisition Proposals ,Company Board Recommendation Change ,Chancery List ,Mergerto Holders ,Approvals Required ,Acceptable Confidentiality Agreement ,Superior Proposal ,Intervening Event ,Recommendation Notice ,Acquisition Proposals ,Termination Date ,Abbvie Termination Fee ,Dividend Data ,Street Name ,Shares Held ,Voting Instructions ,Record Holders ,Special Meeting Materials ,Additional Information ,Annual Report ,Quarterly Reports ,Restated Registration ,Shareholder Rights Agreement ,Chief Business Development ,Strategic Operations Officer ,Chief Business ,Strategy Officer ,Board Cerevel ,From November ,Unaudited Prospective Financial Information ,Reference Date ,Value Reasonably ,Solicitation Covenants ,Stockholder Participation ,Future Earnings ,Cautionary Statement Regarding ,Looking Statements ,Annexb Centerview ,Draft Merger Agreement ,Internal Data ,Centerview Financial Analysis ,Unaudited Prospective Financial ,Stock Trading Price ,Price Target ,Wall Street ,Premium Paid ,Bain Capital ,Diversey Holdings ,Arena Pharmaceuticals ,American Institute ,Certified Public Accountants ,Year Ending December ,Unlevered Free Cash Flow ,Convertible Notes ,Make Whole Fundamental Change ,Convertible Notes Indenture ,Make Whole Fundamental Change Conversion Period ,Conversion Rate ,Anthony Coles ,Security Ownership ,Certain Beneficial Owners ,Control Severance Benefits ,Chief Executive ,Severance Benefits Policy ,Csuite Executives ,Senior Vice Presidents ,Vice Presidents ,Employee Director Compensation Policy ,Mitigation Actions ,Severance Benefits ,Delaware Supreme ,Treasury Regulations ,Internal Revenue Service ,Foreign Account Tax Compliance Act ,Federal Trade Commission ,Antitrust Division ,Eastern Time ,Second Request ,Note Regarding ,Disclosure Letter ,Merger Becomes Effective ,Canceled Company Share ,Cerevel Stock Options ,Cerevel Stock Awards ,Entry Share ,Canceled Company ,Cerevel Stock Option ,Securities Act ,Oxley Act ,Foreign Corrupt Practices Act ,Cancelled Company Shares ,License Agreement ,Pfizer License Agreement ,Business Pending ,Worker Adjustment Retraining ,Notification Act ,United States Food ,Cosmetic Act ,United States Public Health Service Act ,Cerevel Product ,Related Actions ,Cerevel Stockholder ,Excluded Benefits ,Markets Authority ,Enterprise Act ,Indemnified Persons ,Indemnified Person ,Indemnified Proceeding ,Conversion Consideration ,Cerevel Termination ,Each Company Share ,Potential Payments ,Named Executive Officers ,Advisory Vote ,Merger Compensationproposal ,Bain Capital Private Equity ,Boulevard East ,Perceptive Life Sciences Master Fund ,Managing Director ,Ronaldc Renaud Jr Trust ,Bain Capital Life Sciences Investors ,Investor Relations ,Further Ownership Rights ,Financial Advisor ,Beach Party ,Board Recommendation ,Confidentiality Agreement ,Sherman Antitrust Act ,Clayton Act ,Federal Trade Commission Act ,Foreign Antitrust Laws ,Intellectual Property Rights ,Material Adverse Effect ,Legal Proceeding ,Legal Proceedings ,Preferred Stock ,Registered Intellectual Property Rights ,Stock Awards ,Istock Plan ,Convertible Senior Notes Due ,Notes Indenture ,Disease Control ,Coronavirus Aid ,Economic Security Act ,Families First Coronavirus Response Act ,Protection Laws ,Protection Requirements ,Data Protection Laws ,Personal Information ,United States Department ,Hazardous Substances ,Comprehensive Environmental Response ,Liability Act ,Hazardous Materials Transportation Act ,Resource Conservation ,Recovery Act ,Clean Water Act ,Clean Air Act ,Safe Drinking Water Act ,Toxic Substances Control Act ,Federal Insecticide ,Rodenticide Act ,Occupational Safety ,Health Act ,Award Exchange Ratio ,Parent Common Stock ,Effective Date ,Employee Retirement Income Security Act ,Environmental Law ,Care Laws ,Federal Food Drug ,Anti Kickback Statute ,Physician Payments Sunshine Act ,False Claims Act ,False Claims Law ,Healthcare Fraud Statute ,Hart Scott Rodino Antitrust Improvements Act ,Property Rights ,Domain Names ,Common Stock ,Governmental Authorities ,Company Disclosure ,Data Protection ,Research Collaboration Agreement ,Trade Controls ,Donetsk People ,Luhansk People ,Sanctioned Country ,Sarbanes Oxley Act ,United States Securities ,Business Day ,Business Days ,Surviving Corporation ,Option Consideration ,Parent Common ,Offering Period ,Exercise Date ,Final Exercise Date ,Paying Agent ,Investors Service ,Book Entry Shares ,Book Entry Share ,Risk Factors ,Impairment Effect ,Company Material Adverse ,Company Preferred ,Capitalization Date ,Company Stock Awards ,Each Company Stock Award ,Each Subsidiary ,Subsidiary Securities ,Company Subsidiary ,Stockholder Approval ,Antitrust Laws ,Material Contract ,Permitted Liens ,Company Impairment ,Beach Plan ,Multiemployer Plan ,Collective Bargaining Agreement ,Tax Returns ,Treasury Regulation ,Tax Return ,Environmental Laws ,Intellectual Property ,Covered Rights ,Company Registered Intellectual Property ,Company Intellectual Property ,Data Protection Requirements ,Data Protection Requirement ,Property Leases ,Real Property Lease ,Enforceability Exceptions ,Real Property ,Incidental Contracts ,Bargaining Agreement ,Health Care ,Untrue Statements ,Material Facts ,Illegal Gratuities ,Corruption Laws ,Sanctioned Person ,Takeover Statutes ,Proxy Statement ,Stockholders Meeting ,Neither Parent ,Certain Arrangements ,Support Agreements ,Related Party ,Related Parties ,Intellectual Property Right ,Developed Compound ,Licensee Selected Compound ,Board Recommendation Change ,Recommendation Change ,Notice Period ,Material Contracts ,Party Consent Payments ,Relevant Business ,Report Form ,Foreign Antitrust Law ,Foreign Antitrust ,Surviving Company ,Antitrust Law ,Antitrust Jurisdiction ,Continuing Employee ,New Plans ,New Plan ,Old Plan ,Continuing Employees ,Sub Stockholder ,Specified Antitrust Jurisdictions ,Specified Antitrust Jurisdiction ,Willful Breach ,Stockholder Meeting ,Parent Termination Fee ,Wall Street Journal ,Executive Vice President ,General Counsel ,Mutual Confidential Disclosure Agreement ,Company Related Parties ,Parent Related Parties ,Presumption Against Drafting ,Page Intentionally Left Blank ,Vice President ,Chief Financial ,Signature Page ,Astrazeneca Rare Disease ,Draft Agreement ,Annual Reports ,Agreement Until ,Proxy Card ,Proxy Card Fold ,Stockholders For ,Directors The ,Named Proxies ,Stockholders Please ,Date Signature ,